These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 637864)

  • 1. Study of a possible structural relationship between thymopoietin and the facteur thymique serique.
    Folkers K; Wan YP
    Biochem Biophys Res Commun; 1978 Feb; 80(4):740-4. PubMed ID: 637864
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction between thymopoietin and facteur thymique serique in the rosette inhibition assay.
    Iwata T; Incefy GS; Good RA
    Biochem Biophys Res Commun; 1979 Jun; 88(4):1419-24. PubMed ID: 475791
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of thymopoietin peptides with the specific receptor of facteur thymique serique (FTS).
    Gastinel LN; Pleau JM; Goldstein G; Bach JF
    Thymus; 1983 Mar; 5(2):78-87. PubMed ID: 6304947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of analogs of the serum thymic nonapeptide, "facteur thymique serique" (FTS). Part I.
    Blanot D; Martinez J; Auger G; Bricas E
    Int J Pept Protein Res; 1979 Jul; 14(1):41-56. PubMed ID: 489246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of analogs of the serum thymic nonapeptide, "facteur thymique serique" (FTS). Part II.
    Martinez J; Blanot D; Auger G; Sasaki A; Bricas E
    Int J Pept Protein Res; 1980 Oct; 16(4):267-79. PubMed ID: 7193192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino acid sequence of thymopoietin isolated from skin.
    Audhya TK; Goldstein G
    Ann N Y Acad Sci; 1988; 548():233-40. PubMed ID: 3247999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses and structure-activity relationships of thymopoietin.
    Abiko T
    Adv Exp Med Biol; 1987; 223():153-5. PubMed ID: 3447432
    [No Abstract]   [Full Text] [Related]  

  • 8. Complete amino acid sequences of bovine thymopoietins I, II, and III: closely homologous polypeptides.
    Audhya T; Schlesinger DH; Goldstein G
    Biochemistry; 1981 Oct; 20(21):6195-200. PubMed ID: 7306506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and complete amino acid sequence of human thymopoietin and splenin.
    Audhya T; Schlesinger DH; Goldstein G
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3545-9. PubMed ID: 3473468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting biological activities of thymopoietin and splenin, two closely related polypeptide products of thymus and spleen.
    Audhya T; Scheid MP; Goldstein G
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2847-9. PubMed ID: 6585832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin.
    Goldstein G; Scheid MP; Boyse EA; Schlesinger DH; Van Wauwe J
    Science; 1979 Jun; 204(4399):1309-10. PubMed ID: 451537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Structural similarity and functional activity of molecular fragments of staphylococcal enterotoxin B and thymopoietin II].
    Vegner RE; Rituma IR; Chipens GI; Duplishcheva AP; Mysiakin EB
    Bioorg Khim; 1987 Jan; 13(1):122-4. PubMed ID: 3566816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymopoietins and long postsynaptic neurotoxins share common information in their primary structures.
    Skerl V; Pavlović M
    FEBS Lett; 1988 Oct; 239(1):141-6. PubMed ID: 3181420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of variation in facteur thymique sérique activity in moderately and severely malnourished Senegalese children.
    Maire B; Wade S; Bleiberg F; Dardenne M; Parent G; Le François P; Carles C
    Am J Clin Nutr; 1982 Dec; 36(6):1129-33. PubMed ID: 6816060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syntheses and effects of [Glu34]-thymopoietin II fragment 32-45 and its analogs on the impaired T-cell transformation in a patient with common variable immunodeficiency.
    Abiko T; Shishido H; Sekino H
    Biotechnol Appl Biochem; 1986; 8(2-3):160-71. PubMed ID: 3488750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of the nonatetracontapeptide corresponding to the sequence proposed for thymopoietin II.
    Fujino M; Shinagawa S; Fukuda T; Takaoki M; Kawaji H
    Chem Pharm Bull (Tokyo); 1977 Jun; 25(6):1486-9. PubMed ID: 890863
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of facteur thymique sérique (FTS) in the thymus. I. Fixation of anti-FTS antibodies on thymic reticulo-epithelial cells.
    Monier JC; Dardenne M; Pléau JM; Schmitt D; Deschaux P; Bach JF
    Clin Exp Immunol; 1980 Dec; 42(3):470-6. PubMed ID: 7011612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of the Gln1-facteur thymique serique and its evaluation with human E-rosette bioassay.
    Konopinska D; Kubik A; Lange A; Siemion IZ; Slopek S
    Mol Immunol; 1980 Oct; 17(10):1213-8. PubMed ID: 7193284
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of the nonatetracontapeptide corresponding to the entire amino acid sequence of thymopoietin I and its effect on the low E-rosette-forming cells of a uremic patient.
    Abiko T; Sekino H
    Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1583-91. PubMed ID: 4042234
    [No Abstract]   [Full Text] [Related]  

  • 20. Generation of a monoclonal antibody against facteur thymique serique (FTS).
    Ohga K; Incefy GS; Wang CY; Good RA
    Clin Exp Immunol; 1982 Mar; 47(3):725-34. PubMed ID: 7044627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.